109 related articles for article (PubMed ID: 6605190)
1. Chromosome abnormality in a human TCGF-dependent T-lymphocyte culture generated against autologous melanoma cells in vitro.
Knuth A; Jhanwar SC; Chaganti RS
Cancer Genet Cytogenet; 1983 Nov; 10(3):277-82. PubMed ID: 6605190
[TBL] [Abstract][Full Text] [Related]
2. T cell growth factor from human splenic cell cultures: conditions for its production, and its utilization for maintenance of cytotoxic T cell lines.
Tanaka Y; Sugamura K; Hinuma Y
Microbiol Immunol; 1981; 25(10):1077-86. PubMed ID: 6273698
[TBL] [Abstract][Full Text] [Related]
3. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin 2-dependent T-cell cultures.
Knuth A; Danowski B; Oettgen HF; Old LJ
Proc Natl Acad Sci U S A; 1984 Jun; 81(11):3511-5. PubMed ID: 6610177
[TBL] [Abstract][Full Text] [Related]
4. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
[TBL] [Abstract][Full Text] [Related]
5. Lysis of fresh and cultured autologous tumor by human lymphocytes cultured in T-cell growth factor.
Lotze MT; Grimm EA; Mazumder A; Strausser JL; Rosenberg SA
Cancer Res; 1981 Nov; 41(11 Pt 1):4420-5. PubMed ID: 6975652
[TBL] [Abstract][Full Text] [Related]
6. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
7. Human T lymphocytes grown in T-cell growth factor: functional attributes in MLC, CML, PLT and allogeneic suppression.
Pawelec G; Rehbein A; Müller C; Sonneborn HH; Wernet P
Immunology; 1981 Apr; 42(4):529-40. PubMed ID: 6453828
[TBL] [Abstract][Full Text] [Related]
8. The use of supernatants from neuraminidase and galactose oxidase (NAGO)-treated lymphocytes as a source of T cell growth factor.
Berzins T; Wikén M; Hellström U; Perlmann P
J Immunol Methods; 1983 Oct; 63(3):309-19. PubMed ID: 6605390
[TBL] [Abstract][Full Text] [Related]
9. Melanoma-specific cytotoxic T cells generated from peripheral blood lymphocytes. Implications of a renewable source of precursors for adoptive cellular immunotherapy.
Slingluff CL; Darrow TL; Seigler HF
Ann Surg; 1989 Aug; 210(2):194-202. PubMed ID: 2787972
[TBL] [Abstract][Full Text] [Related]
10. Mitogenic and mitogenically defective phytohemagglutinin isolectins stimulate T-cell growth factor (interleukin 2) production and response in fresh and cultured human T lymphocytes.
Hernandez DE; Leavitt RD
Cell Immunol; 1984 Jun; 86(1):101-8. PubMed ID: 6609774
[TBL] [Abstract][Full Text] [Related]
11. Cytolysis of autologous fresh osteosarcoma cells by human cytotoxic T lymphocytes propagated with T cell growth factor.
Ichino Y; Ishikawa T
Gan; 1983 Aug; 74(4):584-94. PubMed ID: 6605270
[TBL] [Abstract][Full Text] [Related]
12. Human T-cell cultures with selective autotumor reactivity.
Vánky F; Klein E
Cancer Immunol Immunother; 1982; 14(2):73-7. PubMed ID: 6985460
[TBL] [Abstract][Full Text] [Related]
13. Human T cells specifically activated against autologous malignant melanoma.
Slingluff CL; Darrow TL; Seigler HF
Arch Surg; 1987 Dec; 122(12):1407-11. PubMed ID: 3318756
[TBL] [Abstract][Full Text] [Related]
14. Human cytotoxic T cells specific for autologous melanoma cells: successful generation from lymph node cells in seven consecutive cases.
Slingluff CL; Darrow T; Vervaert C; Quinn-Allen MA; Seigler HF
J Natl Cancer Inst; 1988 Sep; 80(13):1016-26. PubMed ID: 3261800
[TBL] [Abstract][Full Text] [Related]
15. Generation of human cytotoxic T lymphocytes against fresh autologous and allogeneic solid tumors by mixed lymphocyte tumor cell culture with T cell growth factor.
Ichino Y; Ishikawa T
Gan; 1984 May; 75(5):436-41. PubMed ID: 6235143
[TBL] [Abstract][Full Text] [Related]
16. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity.
de Vries JE; Spits H
J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458
[TBL] [Abstract][Full Text] [Related]
17. Lysis of tumor biopsy cells by autologous T lymphocytes activated in mixed cultures and propagated with T cell growth factor.
Vánky F; Gorsky T; Gorsky Y; Masucci MG; Klein E
J Exp Med; 1982 Jan; 155(1):83-95. PubMed ID: 6459402
[TBL] [Abstract][Full Text] [Related]
18. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.
Muul LM; Spiess PJ; Director EP; Rosenberg SA
J Immunol; 1987 Feb; 138(3):989-95. PubMed ID: 3100623
[TBL] [Abstract][Full Text] [Related]
19. T lymphocytes in infectious mononucleosis; effect of IL-2 on the outgrowth of Epstein-Barr virus-infected cells.
Misko IS; Burrows SR; Schmidt C; Bishop CJ; Ryan JM; Staples JA; Moss DJ
Immunol Cell Biol; 1989 Feb; 67 ( Pt 1)():49-55. PubMed ID: 2785955
[TBL] [Abstract][Full Text] [Related]
20. Human T cell growth factor (TCGF) produced by repeated stimulation of non-adherent human lymphocytes.
Wu Y; Ernberg I; Masucci MG; Johnson D; Klein E; Klein G
J Immunol Methods; 1982; 51(1):35-44. PubMed ID: 6809829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
